Cardiolipin IgG Control - ARCSA Registration f634ee006176b0d6e40f05fb2dfc858b
Access comprehensive regulatory information for Cardiolipin IgG Control in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID f634ee006176b0d6e40f05fb2dfc858b and manufactured by SHENZHEN YHLO BIOTECH CO., LTD.. The device was registered on October 12, 2021.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
I
f634ee006176b0d6e40f05fb2dfc858b
Cardiolipin IgG Control
ARCSA ID: f634ee006176b0d6e40f05fb2dfc858b
Device Classification
Risk Class
I
Product Type
In Vitro Diagnostic
Brand Name
YHLO
Commercial Name
17-061 IVD Reagents/Assay Kits, Immunoassay, Control
Registration Information
Analysis ID
f634ee006176b0d6e40f05fb2dfc858b
Registration Date
October 12, 2021
Expiration Date
October 12, 2026
Product Use
CARDIOLIPIN IGG CONTROL IS USED TO CHECK THE RELIABILITY OF THE CARDIOLIPIN IGG ASSAY.
Manufacturer
City
SHENZHEN
Country
CHINA
Address
BUILDING 1, YHLO BIOPARK, BAOLONG 2ND ROAD, BAOLONG SUBDISTRICT, LONGGANG DISTRICT, 518116 SHENZHEN, PEOPLE'S REPUBLIC OF CHINA
Product Owner
Name
SHENZHEN YHLO BIOTECH CO., LTD.
Country
CHINA
Authorized Representative